Australian Luxury Stock News

Pro Medicus (ASX:PME) drew attention after gaining 3.1% as traders reacted to its upcoming removal from the S&P/ASX 50 index. Heavy volumes were linked to index fund adjustments and recent US contract wins. See our latest analysis for Pro Medicus. The recent spike in activity sits against a mixed longer record for Pro Medicus. The 30 day share price return of 36.49% and 90 day return of 46.11% contrast with a year to date share price decline of 21.56% and a 1 year total shareholder return...

In recent commentary, NEXTDC has been highlighted for ramping up AI-focused data centre expansion and capital investment to support rising cloud and computing infrastructure needs across Australia and Southeast Asia. This renewed attention underscores how AI workloads are turning data centre operators like NEXTDC into essential infrastructure providers, with investors closely assessing execution, funding strength and demand signals. With this backdrop, we’ll explore how NEXTDC’s intensified...

Recent coverage has put Weebit Nano in the spotlight as an ASX-listed semiconductor innovator whose ReRAM memory technology is increasingly linked to AI infrastructure and efficiency needs. This focus on “memflation” – tightening memory supply amid rising AI demand – positions Weebit Nano within a broader debate about how future computing hardware will handle power and performance constraints. Against this backdrop, we’ll explore how Weebit Nano’s role in advanced AI memory solutions shapes...

Bega Cheese recently reported a 21% rise in normalised EBITDA for the first half of FY2026, with its Bulk segment EBITDA increasing very large on the back of improved pricing alignment and product mix, and in response upgraded its normalised EBITDA guidance for FY2026 while reiterating its goal of A$250 million EBITDA by FY2028. This combination of stronger interim earnings and a higher full-year EBITDA outlook highlights how operational changes in both Branded and Bulk segments are feeding...

With economic data sending mixed signals on growth, inflation and consumer demand across regions, many investors are looking for stocks where analysts still see clear earnings expansion and balance sheets that can handle bumps in the road. That is exactly what the Healthy high growth potential screener is built to surface, by filtering for companies where analysts currently expect strong earnings growth over the next 3 years and which also meet basic financial strength criteria. In this...

Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...

As Australian shares experience slight fluctuations due to geopolitical tensions, investors are keeping a close eye on market developments. In this context, penny stocks—though an older term—remain relevant as they often represent smaller or emerging companies with potential for growth. By focusing on those with strong financial health, these stocks can offer opportunities for stability and upside potential amidst broader market uncertainties.

Dividend Powerhouses can be useful when you want your portfolio to work for you through regular cash income as well as potential capital gains. With central banks watching inflation, energy markets influencing bond yields and consumers showing mixed strength across regions from Canada to Malaysia, many investors are paying closer attention to companies that pay solid, well covered dividends. This Dividend Powerhouses screener focuses on stocks with yields above 5% that are supported by stable...

CSL has recently attracted renewed investor attention after a difficult period marked by earnings downgrades, operational issues across its plasma and vaccine businesses, restructuring moves, and leadership uncertainty. This shift in sentiment has coincided with heavy trading activity, a rotation toward defensive healthcare names, and anticipation around CSL’s upcoming full-year results and dividend announcement. We’ll now explore how this rebound in interest, amid elevated trading volumes...

ASX (ASX:ASX) is back in focus after reaching a settlement with ASIC over misleading statements about its CHESS replacement project, alongside fresh proposals to tighten share issuance rules in takeover and merger deals. See our latest analysis for ASX. ASX shares have been volatile, with a 5.7% 7 day share price return and a 5.9% 90 day share price return. However, the 1 year total shareholder return has declined 22%, highlighting how the latest legal settlement and governance proposals sit...

Transurban Group has completed the M7–M12 Integration Project in Western Sydney, adding an extra lane each way over 26 kilometres and opening the new M7–M12 interchange, which is expected to ease congestion and improve connections to the Western Sydney (Nancy-Bird Walton) Airport. This project, alongside recent financing moves and asset sales, underlines how Transurban is reshaping its toll road portfolio while aiming to support future traffic capacity and regional development. We’ll now...

Potential Salter Brothers Emerging Companies Limited ( ASX:SB2 ) shareholders may wish to note that the Non Executive...

Why National Australia Bank’s data push matters for investors National Australia Bank (ASX:NAB) is rolling out a conversational analytics tool powered by Databricks’ Genie, aiming to speed up how teams access customer and operational insights across the bank. This move sits alongside growing attention on Australian financial stocks linked to wealth platforms and capital light earnings, with National Australia Bank often used as a reference point when investors compare business models and data...

Evolution Mining (ASX:EVN) is back in focus after reports of record cash generation, a shift to a net cash position and a broker upgrade, all occurring as firm gold prices support sector interest. See our latest analysis for Evolution Mining. At a latest share price of A$12.54, Evolution Mining has seen short term share price momentum soften after a 1 day decline of 5.07%. However, the 1 year total shareholder return of 64.53% and 3 year total shareholder return above 3x indicate that longer...

As Australian shares begin the day with a tentative -0.5% start, investors are eyeing global developments such as the easing of tensions in the Middle East and Wall Street's buoyant performance. In this context, penny stocks present an intriguing opportunity for those looking to explore beyond established market players. Although often considered a throwback term, penny stocks—typically smaller or newer companies—can offer unique growth potential when backed by strong fundamentals and...

TPG Telecom (ASX:TPG) is back in focus after a nationwide Vodafone mobile outage, followed by network restoration and review, and a new infrastructure partnership to support Swoop’s expansion into mobile services. See our latest analysis for TPG Telecom. The recent outage and subsequent recovery come against a mixed share price backdrop for TPG Telecom. The 1-day share price return of 3.26% and 7-day return of 2.43% sit alongside a 30-day share price return that declined 8.87%, while the...

Canaccord Genuity has initiated coverage on Elsight (ASX:ELS), highlighting the company’s role in connectivity solutions for drones and autonomous systems as defence spending by NATO countries responds to ongoing geopolitical tensions in Europe. See our latest analysis for Elsight. At the latest share price of A$7.88, Elsight has seen a 1-day share price return of 1.29% and a 30-day share price return of 38.98%. The 1-year total shareholder return is very large, signalling strong momentum...

Artificial intelligence sits at the center of many of today’s market conversations, from chip supply to cloud spending and software tools like ChatGPT, even as inflation, energy prices and interest rate expectations keep moving the macro backdrop. For investors who want focused exposure without having to sift through every AI headline, this AI Stocks screener targets companies directly tied to semiconductors, software, LLMs, ChatGPT, cloud and broader transformation. In this article, you will...

Generation Development Group (ASX:GDG) is back on radar after record FY2025 results and strong funds under management growth coincided with supportive Division 296 tax settings, which helped drive elevated trading and renewed investor interest. See our latest analysis for Generation Development Group. At A$3.73, Generation Development Group’s share price has seen a sharp 1-day share price return of 4.78% after record FY2025 results and strong funds under management growth, but remains under...

Helia Group Limited has appointed insurance veteran Mark Senkevics as its next CEO and Managing Director, effective on or before 1 December 2026, while confirming Craig Ward will move from Interim CFO to permanent CFO from 1 July 2026 as part of a planned leadership transition. These leadership changes come as analysts rework valuation models and reassess Helia’s position in Australia’s mortgage insurance market, highlighting how management execution could matter more as the industry adjusts...

Penny stocks often attract attention for their low share prices, but the real opportunity can lie in finding companies with healthier balance sheets and cleaner cash flows than the typical early stage stock. With inflation, interest rates and energy costs all pulling markets in different directions, many investors are looking for ways to target potential growth while trying to keep a closer eye on risk. This is where the Financially Fit Penny Stocks screener comes in. It focuses on lower...

With inflation signals, central bank decisions and export data all moving in different directions across major economies, many investors are looking for companies where internal conviction is just as important as external forecasts. Fast growing stocks with high insider ownership can offer that combination, where management and major shareholders are materially aligned with future outcomes. Our Fast Growing Stocks With High Insider Ownership screener focuses on companies that analysts and...

In recent days, Telix Pharmaceuticals and United Imaging Healthcare signed a memorandum of understanding for a research collaboration in the US to combine United Imaging’s advanced scanner, software and AI platforms with Telix’s molecular imaging products, initially centred on TLX101-Px for characterizing recurrent or progressive glioma under FDA review. This alliance underscores Telix’s push to integrate its radiopharmaceutical pipeline with cutting-edge imaging hardware and clinical...

Inflation data, fuel prices and interest rate expectations are moving together in ways that can quickly reshape which Australian stocks look appealing and which might struggle. The extension of the federal fuel excise cut and a modest pullback in headline inflation could ease cost pressures for some companies, while others tied to fuel supply or sensitive to underlying inflation may face tougher conditions. This article breaks down three stocks from the Australian Inflation and Fuel Price...